Latest Posts

Vedanta Demerger: Shareholders approve the proposed 5-unit plan— Key things to know

Vedanta Ltd., a leading private-sector mining giant last week secured approval from its shareholders and creditors to proceed with its much-anticipated demerger plan. The restructuring will result in the creation of five independent, sector-specific entities and the management expects the demerger process to be finalized by the first quarter of the financial year 2026. The...
Read more

IPO News Today Live Updates on February 26, 2025 : Upcoming IPO: Chai Point looking to go public by mid-206, says co-founder Tarun Khanna

IPO News Today Live Updates: Navigate the dynamic world of initial public offerings with our dedicated IPO News section. Here, we bring you the latest updates on companies stepping into the public market, offering insights into their financial strategies, valuation, and market reception. Whether you’re an investor looking for new opportunities or simply curious about...
Read more

Stock to watch tomorrow: Vakrangee shares in focus after this tie-up with Aditya Birla Health Insurance

The share price of Vakrangee will remain in focus on Thursday’s trading session, after the announced a strategic corporate agency tie-up with Aditya Birla Health Insurance Company Limited (ABHICL), the health insurance arm of Aditya Birla Capital. Varkrangee share price has plunged over 5.80 per cent in the last five trading sessions on National Stock...
Read more

THIS Mukul Agrawal’s portfolio aerospace, defence, engineering stock may be in focus on Thursday; here’s why

A mid-cap stock from ace investor Mukul Mahavir Agrawal’s portfolio may grab investors’ attention on Thursday, February 27, as the Indian stock market reopens after the Mahashivratri holiday. This renewed focus could stem from the company’s investor presentation on February 25. PTC Industries’ share price, down over 28% in February so far, may attract long-term...
Read more
1 29 30 31 32 33

Trending News

Editor's Picks

Alkem launches generic empagliflozin low-cost diabetes drug in India

Mumbai-based Alkem Laboratories announced today the launch of generic empagliflozin and its combinations in India under the brand name “Empanorm.” The medication, which treats type-2 diabetes, chronic kidney disease, and heart failure, will be priced approximately 80 per cent lower than innovator products. The shares of Alkem Laboratories Limited were trading today at ₹4,709 down...

ALL INDIA MSMES PROMOTION AND WELFARE ASSOCIATION

Quick Links

Popular Categories

Must Read

AIMPWA © 2025- All Right Reserved. Designed and Developed by  growGX.com